Total Funding
3
1
Total FundingSeries A raised
Growth Score 3 in past quarter
-6 pts
Heat Score 1 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
769116
PIN Pharma is a biopharmaceutical company
- Mark Smith: Corporate Secretary, Chief Business Officer, Chief Finance Officer, Business Development
- Colin Bier: President, CEO
About the Company
A biopharmaceutical company focused on developing broad-base immuno-modulatory therapies, using an innovative approach to link the innate and adaptive immune systems. PIN Pharma is a private, venture-backed research and development company that is focused on developing immunotherapies. Its first therapeutic area of focus is oncology; however, its
technology is applicable to a myriad of other disease areas.
